JDD Special Focus

Acne Podcast Episodes

Stay up-to-date on new clinical findings on Acne. View the latest articles, case reports, editorial features, supplements, Podcast episodes and more!

 

Podcast Episodes

Ask the Investigator: Acne, OCPs, and a Side Order of Practical Pearls for the Adolescent Patient

 

JDD Podcast host Dr. Adam Friedman gets first-hand insight from internationally acclaimed pediatric dermatologist Dr. Lawrence Eichenfield on his recent study entitled “Hormonal Contraceptives and Acne: A Retrospective Analysis of 2147 Patients” published in the June 2016 edition of the Journal of Drugs of Dermatology. Want a refresher on the use of OCPs in Acne?

Interested in learning how to initiate a patient based survey study? Just curious how a leader in the field gets an uninterested adolescent to be compliant and engaged in his/her acne care? These are just a few of the practical pearls provided.

Sponsored

Featured Editorials

Virtual Exams No Substitute for In-Person Care of Acne and Rosacea

Some dermatologists may be surprised to hear that the concept of teledermatology originated 25 years ago, and has slowly increased in usage, primarily for the purpose of providing care to those in underserved areas.1 The challenges created by the COVID19 pandemic has rapidly accelerated both interest and usage of telemedicine by dermatologists, with the American Academy of Dermatology and other dedicated groups responding quickly to provide guidance on how to integrate teledermatology into real-world dermatology practice effectively, and hopefully with avoidance of technical, medicolegal, and financial pitfalls.2

 

Read Now

Sponsored

Featured Supplement

Androgens, Androgen Receptors, and the Skin

Of the four primary pathogenic factors that drive acne vulgaris—androgen excess, increased sebum production, faulty keratinization, and overgrowth of C. acnes—androgen excess has been the most elusive therapeutic target. Oral contraceptive pills (OCPs) have direct effect on circulating hormones, but their potential use is limited to a subset of women. As such, a sizable portion of the population affected by acne vulgaris cannot even consider treatment with OCPs. While these systemic agents are generally associated with a low risk profile and have a history of safe and effective use, they are not entirely risk-free. Indirect androgen modulation has become increasingly popular. Again, while generally safe and effective, this systemic treatment is not without risks and contraindications and it is also limited to a subset of female patients.

Read Now

Dermatology News

Journal of Drugs in Dermatology JDD Article About Is Upadacitinib Cardioprotective in Chronic Inflammatory Diseases? A Review of Major Adverse Cardiovascular Events and Venous Thromboembolism in Atopic Dermatitis. Image is from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas of a darker skin tone with atopic dermatitis (AD) on their arm.Atopic DermatitisFeatured ArticlesLatest NewsMedical DermThe Latest
June 16, 2025

Is Upadacitinib Cardioprotective in Chronic Inflammatory Diseases? A Review of Major Adverse Cardiovascular Events and Venous Thromboembolism in Atopic Dermatitis

Could an Eczema Treatment Also Protect the Heart? Looking at Upadacitinib and Cardiovascular Risk Atopic dermatitis (AD) may start on the skin, but its impact goes much deeper. As a…
Journal of Drugs in Dermatology JDD Article About Practical Algorithm on Topical Treatment of Flaring Atopic Dermatitis (AD) With or Without Secondary Infection.Atopic DermatitisFeatured ArticlesLatest NewsThe Latest
June 13, 2025

Practical Algorithm on Topical Treatment of Flaring Atopic Dermatitis (AD) With or Without Secondary Infection

Taming the Flare: A Practical Algorithm for Managing Atopic Dermatitis with or without Infection For patients with atopic dermatitis (AD), flares aren’t just a passing inconvenience, they can be emotionally…
Journal of Drugs in Dermatology JDD Article About Acne Awareness Month. The image is from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas. It shows a pediatric patient with light skin tone and acne, along with hyperpigmentation.AcneFeatured ArticlesLatest NewsThe Latest
June 12, 2025

Acne Awareness Month

Acne Awareness Month: Spotlight on Innovation, Impact, and Individualized Care June is Acne Awareness Month, a timely reminder that acne vulgaris is more than a rite of passage—it’s a complex, chronic…
Journal of Drugs in Dermatology JDD Article About The Impact on Acne Treatment Regimens if Benzoyl Peroxide-Containing Products are Removed From the Market. Image from The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas of a patient with skin of color who has acne and hyperpigmentation from acne scarring.AcneFeatured ArticlesLatest NewsThe Latest
June 11, 2025

The Impact on Acne Treatment Regimens if Benzoyl Peroxide-Containing Products are Removed From the Market

If Benzoyl Peroxide Disappears: What’s Next for Acne Treatment? Benzoyl peroxide (BPO) has long been a staple in acne therapy—widely used, well-understood, and highly effective. But its future on the…